IP Verse

Onyx Therapeutics competitive analysis

Loading summary...

Latest patents of Onyx Therapeutics opposed by its competitors

Explore Onyx Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2662094
Apr 17, 2024Cylodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors6

Latest publications and patents of Onyx Therapeutics New

Explore the latest publications and patents granted to Onyx Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 20, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Onyx Therapeutics

EP2662094
Apr 17, 2024Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsGranted And Under Opposition

Latest PTAB cases involving Onyx Therapeutics

Discover the latest PTAB cases involving Onyx Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Onyx Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ONYX THERAPEUTICS - 6 - -
BRAND MURRAY FULLER23 - - -
FRESENIUS KABI DEUTSCHLAND11918 - -
HGF74 - - -